Please use this identifier to cite or link to this item: doi:10.22028/D291-30899
Title: An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2
Author(s): Wagmann, Lea
Maurer, Hans H.
Meyer, Markus
Language: English
Title: Journal of Chromatography A
Volume: 1521
Pages: 123-130
Publisher/Platform: Elsevier
Year of Publication: 2017
Free key words: ADP quantification
HILIC-HR-MS/MS
hBCRP ATPase
hBCRP substrate
hBCRP inhibitor
HIV protease inhibitors
DDC notations: 570 Life sciences, biology
Publikation type: Journal Article
Abstract: Interactions with the human breast cancer resistance protein (hBCRP) significantly influence the pharmacokinetic properties of a drug and can even lead to drug-drug interactions. As efflux pump from the ABC superfamily, hBCRP utilized energy gained by adenosine 5′-triphosphate (ATP) hydrolysis for the transmembrane movement of its substrates, while adenosine 5′-diphosphate (ADP) and inorganic phosphate were released. The ADP liberation can be used to detect interactions with the hBCRP ATPase. An ADP quantification method based on hydrophilic interaction liquid chromatography (HILIC) coupled to high resolution tandem mass spectrometry (HR-MS/MS) was developed and successfully validated in accordance to the criteria of the guideline on bioanalytical method validation by the European Medicines Agency. ATP and adenosine 5′-monophosphate were qualitatively included to prevent interferences. Furthermore, a setup consisting of six sample sets was evolved that allowed detection of hBCRP substrate or inhibitor properties of the test compound. The hBCRP substrate sulfasalazine and the hBCRP inhibitor orthovanadate were used as controls. To prove the applicability of the procedure, the effect of amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir on the hBCRP ATPase activity was tested. Nelfinavir, ritonavir, and saquinavir were identified as hBCRP ATPase inhibitors and none of the five HIV protease inhibitors turned out to be an hBCRP substrate. These findings were in line with a pervious publication.
DOI of the first publication: 10.1016/j.chroma.2017.09.034
Link to this record: urn:nbn:de:bsz:291--ds-308997
hdl:20.500.11880/29168
http://dx.doi.org/10.22028/D291-30899
ISSN: 0021-9673
Date of registration: 19-May-2020
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Prof. Dr. Markus Meyer
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
An easy and fast adenosine 1 5'-diphosphate_mit_Vorblatt.pdfAccepted Manuscript696,15 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons